Liar, liar, panties on fire.
do not cover that short position!
It WILL go back down after a short rise
Don't worry! HALO will crash like a rock so DO NOT COVER THAT SHORT in afterhours.
I super guarantee it!
(Hey, if I'm wrong I'll pay your losses)
SO HANG ON TO THAT SHORT POSITION!
So much going on I get confused.
Can you give me a ballpark timetable of upcoming events/expected approvals/etc.
There you go! "Penny stock territory"
Now you're talkin...
Whatever you do... Don't cover that short!
You're gonna be a gagamegatrazillionaire in a very short time.
I guarantee it!
YEAH! Short some more.
That's the ticket.
whatever you do, don't cover that short. It's sure to get back to your break even point.
I can almost promise it. Trust me!
Better yet, short some more!
It may dip a bit based on runup, but I don't know if that article has anything to do with it. I actually took profits a week ago (too soon) and bought back in higher. The good thing is I don't own as much now so any drop is to me a great buy opp. If it goes to low $13's I'll be piling more on.. This stock will hit $18 - $20 in a year if not sooner. Longer term look to see it triple.
I agree. I owned AUY because I thought gold had bottomed, if only temporarily. Same I'm guessing with everybody else who's long here. Six months to a year from now maybe we'll be looking back thinking what geniuses we all were.
You said, "Tell me where I may be wrong"
All I can do it guess, but the judgement amount was known before today's trading, so I think that at least partially it should have been priced in. Also, my logic openly claims that even if the money raised from the offering is 100% #$%$ away, the value should still be around $4.47/share. AUY may drop below that for a few days, but if today's $4.73 was a fair value (Substitute whatever word you want for "fair". I said "accurate" before and was called on it. We all know that any stock's daily price is just whatever the combined opinions of millions of buyers/sellers agree on, and that it changes daily), then it should return to it if the price of gold continues upward, and any price much lower is still a great buy op..
What I started my post with stands. People "assume" the worst when shares are sold, but usually that sell off is temporary. What I finished with stands also. The market valued AUY at $4.73/share at close of business today. If gold prices continue to climb, then whatever the short term results may be, it will return to the $4.47 valuation of today and should keep moving up. $4.47 is in my opinion a screaming buy.
Why do people always assume that selling more shares is "dilution" and buying back shares increases shareholder equity. Assuming that the $4.73 close today was an accurate valuation for this company, any drop below about $4.47 is a screaming buy opportunity, and that's EVEN IF ALL of the money raised in the share sale is 100% #$%$ away and not used to reduce debt or help the company.
877,590,000 (current shares outstanding)
49,200,000 (shares being sold in the offering)
=926,790,000 (shares outstanding after the offering)
$4,150,000,000 (current market cap (as per Yahoo)/ 926,790,000 shares = $4.48/share
And again, this is with the totally invalid assumption that NO money raised from the sale would have any effect on the value of the company.
AUY is a screaming BUY anywhere below about $4.55 or even higher.
One PR release said they Shire expected the deal to close during the first Quarter of the year, which means from today sometime between now and March 31 or 79 days. The $46 represents about 1% increase over the $45.44 over that 79 days or about 4.6% per year if it goes all the way to the end of the quarter. Is the 1% extra worth it to you to hold another 79 days? It's up to you.
For some reason Gilron cusses out everybody. Just put him on ignore.
I googled "what is the compassionate use rule" and found this:
You may pay out of pocket for experimental treatment. The drug company may charge you for the experimental drug. Also, your insurance company is unlikely to pay associated costs of your treatment, such as fees for your doctor to administer the experimental drug and monitor side effects.
But even if HALO charged, it looks like it would be pretty cumbersome and highly individualistic to get approval, so there would be few patients using this option, so the effect to revenue would be minimal.
If this compassionate use was granted, do you have any idea/guesstimate as to how much it would effect the projected revenue for the year?
Very optimistic. I'm guessing that the number of patients NSP will treat will be very much less the 40K your model predicts.
That said, I think $70/share is way too low. We may see the $168+$30 but I think it will take 5 years. In my opinion, that ain't bad.
I hope that you're timeline is "righter" than mine.